Bristol Myers Squibb , Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for ...

Scientists have achieved a new feat in molecular editing by swapping carbon for nitrogen, enabling the direct conversion of ...

Multinational pharmaceutical companies were seeing a “reverse” in the technological gap between Biomap and AlphaFold, Wei Liu ...

Overview: Quantum computing holds potential to speed up complex protein structure modeling.Current limitations keep it more ...

Craig Thompson, CEO of Cerevance touches on the NETSseq platform and how it shapes Cerevance's approach to the drug discovery strategy.

Naloxone, the drug typically used to stop an opioid overdose, only works for about 30 minutes. That means it often needs to be administered multiple times to prevent an overdose death. As overdose ...

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, ...

Proposed NIH funding cuts are a pressing concern when one considers the broader impacts of reduced research funding.

N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the RTB ...

Artificial intelligence is poised to dramatically reshape the process of developing and approving new medicines, according to ...

Officials at Concept Life Sciences say the company’s headquarters is now one of the U.K.’s largest drug discovery research sites.